Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation

Dympna Morrow, P. Fitzsimons, Mridula Chopra, H. McGlynn

Research output: Contribution to journalArticlepeer-review

Abstract

Dietary modification, especially the consumption of larger amounts of fruits and vegetables can act to decrease the risk of a variety of human cancers. Quercetin, a bioflavonoid widely distributed in fruits and vegetables has been shown to have a chemoprotective role in cancer, through complex effects on signal transduction involved in cell proliferation and angiogenesis. In this study we examined the effects of dietary supplementation of quercetin (30 mg per day) incorporated into a blackcurrant drink. Healthy male subjects aged between 33 and 64 years (mean=47.1 years) received either quercetin or placebo for 14 days. Blood samples were taken at baseline and upon completion of the study and analysed for full blood count, matrix metalloproteinase-2 (MMP-2), tissue inhibitor of matrix metalloproteinse-1 and -2 (TIMP-1 and -2) plasma levels using ELISA techniques. RNA was extracted from the peripheral blood lymphocytes and reverse transcriptase–polymerase chain reaction (RT–PCR) carried out for MMP-2 and TIMP-1, TIMP-2 gene expression determination. Supplementation of the diet with quercetin did not alter the MMP-2 or TIMP-2 gene transcription or plasma protein levels of the healthy subjects in this study. The TIMP-1 gene transcription and plasma protein levels (311±70 ng/ml at baseline to 183±35 ng/ml post-supplementation, P
Original languageEnglish
Pages (from-to)269-276
Number of pages8
JournalMutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
Volume480-1
DOIs
Publication statusPublished - 1 Sep 2001

Fingerprint

Dive into the research topics of 'Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation'. Together they form a unique fingerprint.

Cite this